Fresenius Medical Care Ag American Depositary Shares (Each Representing 1/2 Of An Ordinary Share) (FMS) closed at $21.56 on October 21, 2026, up 0.7% from the previous close, on volume of 1,060,961 shares (30-day average 1,021,324).
Data as of October 21, 2026.
DZ BANK AG Remains a Buy on Fresenius Medical Care AG & Co. KGaA (0H9X)
TipRanks (Thu, 22-Oct 2:35 AM ET)
PRNewswire (Wed, 21-Oct 6:13 PM ET)
DaVita, Fresenius drop as RFK Jr. is said to plan dialysis market reforms
Seeking Alpha News (Tue, 20-Oct 12:57 PM ET)
UBS Sticks to Its Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
TipRanks (Tue, 20-Oct 4:05 AM ET)
PRNewswire (Mon, 19-Oct 9:01 AM ET)
TipRanks (Mon, 19-Oct 7:25 AM ET)
Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Hold from Deutsche Bank
TipRanks (Mon, 19-Oct 4:55 AM ET)
J.P. Morgan Sticks to Their Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
TipRanks (Mon, 19-Oct 2:25 AM ET)
Market Chameleon (Thu, 8-Oct 5:10 AM ET)
PRNewswire (Wed, 7-Oct 11:28 AM ET)
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
Fresenius Medical Care Ag American Depositary Shares (Each Representing 1/2 Of An Ordinary Share) trades on the NYSE stock market under the symbol FMS.
As of October 22, 2026, FMS stock price climbed to $22.11 with 499,307 million shares trading.
FMS has a beta of 0.28, meaning it tends to be less sensitive to market movements. FMS has a correlation of 0.02 to the broad based SPY ETF.
FMS has a market cap of $11.88 billion. This is considered a Large Cap stock.
Last quarter Fresenius Medical Care Ag American Depositary Shares (Each Representing 1/2 Of An Ordinary Share) reported $6 billion in Revenue and $.66 earnings per share. This fell short of revenue expectation by $-69 million and exceeded earnings estimates by $.02.
In the last 3 years, FMS traded as high as $30.46 and as low as $16.37.
The top ETF exchange traded funds that FMS belongs to (by Net Assets): PZLV, AVDE, APIE, TIIV, CVAR.
FMS has underperformed the market in the last year with a return of -15.3%, while the SPY ETF gained +14.7%. In the last 3 month period, FMS fell short of the market, returning -10.4%, while SPY returned +2.1%. However, in the most recent 2 weeks FMS has outperformed the stock market by returning +6.9%, while SPY returned -1.9%.
FMS support price is $21.18 and resistance is $21.94 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FMS shares will trade within this expected range on the day.
